MX2013011200A - Preparacion de ester de 3,5-dioxohexanoato en dos etapas. - Google Patents
Preparacion de ester de 3,5-dioxohexanoato en dos etapas.Info
- Publication number
- MX2013011200A MX2013011200A MX2013011200A MX2013011200A MX2013011200A MX 2013011200 A MX2013011200 A MX 2013011200A MX 2013011200 A MX2013011200 A MX 2013011200A MX 2013011200 A MX2013011200 A MX 2013011200A MX 2013011200 A MX2013011200 A MX 2013011200A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- steps
- hexanoate ester
- dioxo
- dioxo hexanoate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/03—Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/04—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides onto unsaturated carbon-to-carbon bonds
- C07C67/05—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides onto unsaturated carbon-to-carbon bonds with oxidation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/28—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
- C07C67/297—Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/317—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C67/32—Decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
La invención divulga un método para la preparación de 6-cloro-3,5-dioxohexanoato terc-butílico a partir de derivado de ácido de Meldrum y su uso para la preparación de (4R,6S)-(6-hidroximetil-2,2-dimetil-1,3-dioxan-4-il)acetato terc-butílico (BHA), Rosuvastatina y Atorvastatina.
Applications Claiming Priority (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161470548P | 2011-04-01 | 2011-04-01 | |
EP11002723 | 2011-04-01 | ||
US201161472820P | 2011-04-07 | 2011-04-07 | |
EP11002922 | 2011-04-07 | ||
US201161526307P | 2011-08-23 | 2011-08-23 | |
US201161526321P | 2011-08-23 | 2011-08-23 | |
EP11006872 | 2011-08-23 | ||
EP11006862 | 2011-08-23 | ||
EP11007606 | 2011-09-19 | ||
EP11007605 | 2011-09-19 | ||
EP12150868 | 2012-01-12 | ||
EP12150867 | 2012-01-12 | ||
PCT/EP2012/055581 WO2012130919A1 (en) | 2011-04-01 | 2012-03-29 | Preparation of 3,5-dioxo hexanoate ester in two steps |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2013011200A true MX2013011200A (es) | 2014-03-12 |
MX337105B MX337105B (es) | 2016-02-09 |
Family
ID=46929511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013011200A MX337105B (es) | 2011-04-01 | 2012-03-29 | Preparacion de ester de 3,5-dioxohexanoato en dos etapas. |
Country Status (13)
Country | Link |
---|---|
US (2) | US8859786B2 (es) |
EP (1) | EP2694490B1 (es) |
JP (1) | JP5960243B2 (es) |
KR (1) | KR101778345B1 (es) |
CN (1) | CN103476763B (es) |
CA (2) | CA2987775C (es) |
EA (1) | EA023490B1 (es) |
ES (1) | ES2669574T3 (es) |
HK (1) | HK1188774A1 (es) |
IL (1) | IL228519A (es) |
MX (1) | MX337105B (es) |
TW (2) | TW201245171A (es) |
WO (2) | WO2012130920A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5960243B2 (ja) * | 2011-04-01 | 2016-08-02 | ロンザ リミテッドLonza Limited | 2工程での3,5−ジオキソヘキサン酸エステルの製造 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH492670A (de) * | 1968-04-24 | 1970-06-30 | Lonza Ag | Verfahren zur Herstellung von y-Chloracetessigsäureester |
IN151753B (es) * | 1980-04-02 | 1983-07-23 | Lonza Ag | |
DE3741509A1 (de) | 1987-12-08 | 1989-06-22 | Hoechst Ag | Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte |
JPH0484893A (ja) * | 1990-07-27 | 1992-03-18 | Chisso Corp | 光学活性1,3―ジオキサン誘導体 |
DK1619191T3 (da) | 1998-08-05 | 2011-01-31 | Kaneka Corp | Fremgangsmåde til fremstilling af optisk aktive 2-[6-hydroxymethyl)-1,3-dioxan-4-yl]-eddikesyre-derivater |
AU2000254249A1 (en) * | 2000-03-28 | 2001-10-08 | Biocon India Limited | Synthesis of (r-(r*,r*))-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1- |
DE10208007A1 (de) | 2002-02-26 | 2003-09-18 | Forschungszentrum Juelich Gmbh | Verfahren zur Herstellung von Alkoholen aus Substraten mittels Oxidoreduktasen, Zweiphasensystem umfassend eine wässrige Phase und eine organische Phase sowie Vorrichtung zur Durchführung des Verfahrens |
AU2004224045A1 (en) * | 2003-03-24 | 2004-10-07 | Sandoz Ag | Novel crystal of 7-[2-(2-aminothiazole-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) and method for preparation thereof |
WO2005054207A1 (en) | 2003-12-04 | 2005-06-16 | Glenmark Pharmaceuticals Limited | Process for the preparation of pyrimidine derivatives |
JP5960243B2 (ja) * | 2011-04-01 | 2016-08-02 | ロンザ リミテッドLonza Limited | 2工程での3,5−ジオキソヘキサン酸エステルの製造 |
-
2012
- 2012-03-29 JP JP2014501608A patent/JP5960243B2/ja not_active Expired - Fee Related
- 2012-03-29 EA EA201301110A patent/EA023490B1/ru not_active IP Right Cessation
- 2012-03-29 ES ES12711863.6T patent/ES2669574T3/es active Active
- 2012-03-29 MX MX2013011200A patent/MX337105B/es active IP Right Grant
- 2012-03-29 TW TW101111031A patent/TW201245171A/zh unknown
- 2012-03-29 CA CA2987775A patent/CA2987775C/en not_active Expired - Fee Related
- 2012-03-29 CN CN201280016819.6A patent/CN103476763B/zh not_active Expired - Fee Related
- 2012-03-29 KR KR1020137028887A patent/KR101778345B1/ko active IP Right Grant
- 2012-03-29 US US14/008,634 patent/US8859786B2/en not_active Expired - Fee Related
- 2012-03-29 WO PCT/EP2012/055582 patent/WO2012130920A1/en active Application Filing
- 2012-03-29 WO PCT/EP2012/055581 patent/WO2012130919A1/en active Application Filing
- 2012-03-29 CA CA2830134A patent/CA2830134C/en not_active Expired - Fee Related
- 2012-03-29 TW TW101111030A patent/TWI551592B/zh not_active IP Right Cessation
- 2012-03-29 EP EP12711863.6A patent/EP2694490B1/en not_active Not-in-force
-
2013
- 2013-09-17 IL IL228519A patent/IL228519A/en active IP Right Grant
-
2014
- 2014-02-24 HK HK14101753.9A patent/HK1188774A1/zh not_active IP Right Cessation
- 2014-08-28 US US14/471,682 patent/US9296718B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL228519A0 (en) | 2013-12-31 |
CN103476763A (zh) | 2013-12-25 |
CA2987775A1 (en) | 2012-10-04 |
CA2987775C (en) | 2019-01-08 |
TW201247640A (en) | 2012-12-01 |
US9296718B2 (en) | 2016-03-29 |
WO2012130920A1 (en) | 2012-10-04 |
TWI551592B (zh) | 2016-10-01 |
KR101778345B1 (ko) | 2017-09-13 |
US8859786B2 (en) | 2014-10-14 |
WO2012130919A1 (en) | 2012-10-04 |
EA023490B1 (ru) | 2016-06-30 |
KR20140034175A (ko) | 2014-03-19 |
US20140371451A1 (en) | 2014-12-18 |
ES2669574T3 (es) | 2018-05-28 |
US20140024842A1 (en) | 2014-01-23 |
MX337105B (es) | 2016-02-09 |
CA2830134A1 (en) | 2012-10-04 |
CA2830134C (en) | 2018-03-06 |
JP2014522377A (ja) | 2014-09-04 |
EA201301110A1 (ru) | 2014-04-30 |
TW201245171A (en) | 2012-11-16 |
EP2694490A1 (en) | 2014-02-12 |
HK1188774A1 (zh) | 2014-05-16 |
IL228519A (en) | 2015-08-31 |
CN103476763B (zh) | 2016-02-03 |
JP5960243B2 (ja) | 2016-08-02 |
EP2694490B1 (en) | 2018-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT2444481T (lt) | Mikroorganizmas, produkuojantis o-fosfoseriną, ir l-cisteino arba jo darinių gamybos būdas, panaudojant o-fosfoseriną | |
EP2812005B8 (en) | Polyhydroxylated pentacyclic triterpene acids as hmg-coa reductase inhibitors | |
IL235944B (en) | Diazabicyclooctane derivative, pharmaceutical preparations containing it, beta-lactamase inhibitors containing it, methods for its preparation and intermediates for the methods | |
EP2588474A4 (en) | PROCESS FOR PREPARING HMG-COA REDUCTASE INHIBITORS AND INTERMEDIATES THEREOF | |
ZA201201974B (en) | Method for the preparation of 2,5-furandicarboxylic acid and for the prepartion of the dialkyl ester of 2,5-furandicarboxylic acid | |
WO2012174487A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2012151512A3 (en) | Bromodomain inhibitors and uses thereof | |
EP2641490A4 (en) | Electronic cigarette, electronic cigarette flare and atomizer thereof | |
WO2012075383A3 (en) | Bromodomain inhibitors and uses thereof | |
WO2013185082A3 (en) | Inhibitors of bruton's tyrosine kinase | |
HK1189223A1 (zh) | 用作β分泌酶 抑制劑的 -二氫-吡咯並 吡嗪- -基胺衍生物 | |
EP2557919A4 (en) | STABILIZED FORMULATIONS OF STATIN | |
AP2010005390A0 (en) | Crystal form of phenylamino pyrimidine derivatives. | |
WO2011142970A3 (en) | Her2 nucleic acid aptamers | |
WO2011133504A3 (en) | Nanozymes, methods of making nanozymes, and methods of using nanozymes | |
EP3243821B8 (en) | Pharmaceutical formulations for regulating integrin cd11b/cd18 | |
WO2013034979A3 (en) | Crystalline forms of cabazitaxel | |
WO2012053794A3 (en) | Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same | |
ZA201208363B (en) | Novel intermediates for the preparation of hmg-coa reductase inhibitors | |
WO2013057013A3 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
EP2833886A4 (en) | SUBSTITUTED QUINOLINES AS INHIBITORS OF BRUTON TYROSINE KINASES | |
WO2010140765A2 (ko) | 로수바스타틴의 신규한 제조방법, 이 제조에 유용한 중간체 화합물 및 그의 제조방법 | |
EP2819798A4 (en) | METAL SPRAY SYSTEM AND METHOD FOR ATOMIZING METALLIC POWDER | |
ZA201306416B (en) | Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a) | |
WO2012150606A3 (en) | A process for preparing stable polymophic form of erlotinib hydrochloride |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |